- Joined
- Oct 20, 2013
- Messages
- 15
- Reaction score
- 1
- Points
- 4,571
- Medical Student
Advertisement - Members don't see this ad
Did people see this NYT article? http://www.nytimes.com/2014/04/09/b...t-big-share-of-payouts.html?ref=business&_r=1
Among other things, it says "About 3,300 ophthalmologists, for example, were paid a total of $3.3 billion from Medicare, according to the Times analysis. Much of the spending was the result of an expensive and frequent treatment for a kind of age-related macular degeneration, the leading cause of severe vision loss in the elderly, and the cost of the drug is factored into the payments doctors receive. Ranibizumab, known by the brand name Lucentis, is injected into the eye as often as once a month. A cancer drug that is used as an alternative can cost much less. "
This is not good publicity for the field...I was surprised to see this article because it seems like most ophthalmologists worry about how low medicare reimbursement has gotten for them. What do others think?
Among other things, it says "About 3,300 ophthalmologists, for example, were paid a total of $3.3 billion from Medicare, according to the Times analysis. Much of the spending was the result of an expensive and frequent treatment for a kind of age-related macular degeneration, the leading cause of severe vision loss in the elderly, and the cost of the drug is factored into the payments doctors receive. Ranibizumab, known by the brand name Lucentis, is injected into the eye as often as once a month. A cancer drug that is used as an alternative can cost much less. "
This is not good publicity for the field...I was surprised to see this article because it seems like most ophthalmologists worry about how low medicare reimbursement has gotten for them. What do others think?
